安纳普蒂斯生物

US · ANAB #3010 按市值排名上市于 2017

46.61 -2.10 -4.31%

实时 - 追踪5344个代码 - 心跳于194秒前 · 2026-10-16 19:30

✦ 量化股权信号计算方式说明

减持

最近一期（2026/Q3）披露持股的机构数量增加了3家。
机构持股总比例下降了1.3个百分点。

机构持股

机构持股比例: 108.19% -1.26pp
机构数量: 261 +3
数据截至: 2026/Q3 较上一报告期

持股变动 vs 资金流向

方向分歧

机构在上一报告期减持了股份，同时该股在最近20个交易日的主力资金呈净流入——两者方向出现分歧。

机构持股变动数据按季度发布且存在滞后；资金流向数据为每日更新。请将其作为方向性的交叉验证参考，而非精确的择时信号。

持股人类型

Mutual Fund49.39%

Hedge Fund47.93%

Public Company6.98%

Individual/Insider2.52%

VC/PE Fund1.65%

Insurance Company1.00%

Private Company0.73%

Government Pension Fund0.49%

主要股东截至 2026-06-30

EcoR1 Capital, LLC 26.36% · 7.88M 股

BlackRock 6.17% · 1.84M 股

Sirenia Capital Management LP 4.99% · 1.49M 股

Tang Capital Management, LLC 4.45% · 1.33M 股

State Street Global Advisors 4.30% · 1.29M 股

Vanguard Capital Management, LLC 3.52% · 1.05M 股

Affinity Asset Advisors, LLC 2.76% · 826.11K 股

Sanofi 2.75% · 821.92K 股

Millennium Management LLC 2.70% · 807.32K 股

Woodline Partners LP 2.40% · 717.01K 股

条形长度是相对于此处列出的最大股东而言，并非相对于公司100%股权。

内部人持股

共追踪50份申报 · 14次买入 · 36次卖出

姓名	职务	持股比例
EcoR1 Capital, LLC	--	26.36%
Daniel Faga	Chief Executive Officer	1.66%
Paul Lizzul	Chief Medical Officer	0.14%
John Schmid	Independent Director	0.13%
John Orwin	Chairperson	0.06%
Dennis Mulroy	Chief Financial Officer	0.05%
Eric Loumeau	Chief Legal Officer	0.04%
Rita Jain	Independent Director	0.04%
Hollings Renton	Lead Independent Director	0.04%
Magda Marquet	Independent Director	0.03%

内部人交易最近的 Form 4 申报记录

日期	姓名	职务	类型	股数	价格
2026-09-30	Hollings Renton	Lead Independent Director	Derivative Exercise and Sale	-5,000	$18.03–49.87
2026-09-14	John Orwin	Chairperson	Derivative Exercise and Retained	+1,300	--
2026-06-28	Dennis Mulroy	Chief Financial Officer	Intent to Sell (Form 144)	-9,476	$63.45
2026-06-25	Dennis Mulroy	Chief Financial Officer	Intent to Sell (Form 144)	-10,000	$60.82
2026-06-16	Dennis Mulroy	Chief Financial Officer	Intent to Sell (Form 144)	-850	$60.00
2026-06-15	Dennis Mulroy	Chief Financial Officer	Intent to Sell (Form 144)	-1,265	$60.00
2026-06-14	John Orwin	Chairperson	Derivative Exercise and Retained	+6,030	--
2026-06-14	Hollings Renton	Lead Independent Director	Derivative Exercise and Retained	+6,030	--
2026-06-14	John Schmid	Independent Director	Derivative Exercise and Retained	+6,030	--
2026-06-14	Dennis Mulroy	Chief Financial Officer	Intent to Sell (Form 144)	-20,000	$57.65
2026-06-11	Dennis Mulroy	Chief Financial Officer	Intent to Sell (Form 144)	-20,000	$55.30
2026-06-10	Dennis Mulroy	Chief Financial Officer	Intent to Sell (Form 144)	-35,000	$52.82
2026-06-09	Dennis Mulroy	Chief Financial Officer	Intent to Sell (Form 144)	-20,000	$52.33
2026-06-08	Dennis Mulroy	Chief Financial Officer	Intent to Sell (Form 144)	-20,000	$51.61
2026-06-07	Dennis Mulroy	Chief Financial Officer	Intent to Sell (Form 144)	-21,987	$50.83
2026-06-04	Dennis Mulroy	Chief Financial Officer	Intent to Sell (Form 144)	-22,491	$51.29
2026-06-03	Dennis Mulroy	Chief Financial Officer	Intent to Sell (Form 144)	-20,000	$51.77
2026-06-02	Dennis Mulroy	Chief Financial Officer	Intent to Sell (Form 144)	-20,000	$50.86
2026-06-01	Dennis Mulroy	Chief Financial Officer	Intent to Sell (Form 144)	-20,000	$51.65
2026-05-31	Dennis Mulroy	Chief Financial Officer	Intent to Sell (Form 144)	-7,691	$52.57

Form 4 申报记录，每家公司显示最新的一批。"Other Derivative Acquisition"（其他衍生品获取）类目多为限制性股票/期权归属，并非公开市场买入——具体类型见"类型"列。

报价时间 2026-10-16 19:30:04 · 仅供参考，不构成投资建议，也未考虑您的具体情况。